Early Access to Medicines Scheme

On 28 April 2014, the ABPI and the BIA jointly organised a stakeholder event in London to publicise the Medicines and Healthcare products Regulatory Agency Early Access to Medicines Scheme (EAMS).

This document provides an executive summary, background, and regulatory, clinical, patient and industry perspectives.